BioAge seeks nearly $200 million in initial public offering
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
FierceBiotech1d
BioAge brings in almost $200M from IPO as obesity biotech joins Nasdaq
BioAge Labs is bringing in almost $200 million via its Nasdaq IPO this morning, with the proceeds earmarked for taking its ...
BioAge prices $198M IPO, validating pivot to obesity drug research
The offering, which was upsized twice, will support development of a drug the company believes can boost the effects of ...
devdiscourse1d
Health Highlights: Abortion Pills, Weight-Loss Drugs, and Fluoride Risks
The health news update discusses Washington state's abortion pill stockpile as a safeguard, BioAge's successful IPO, a ...
BioAge valued at $758 million in debut as investors bet on weight-loss drug frenzy
By Arasu Kannagi Basil and Prakhar Srivastava (Reuters) -Shares of BioAge Labs opened 25% above their initial public offering price on Thursday in a strong debut for the weight-loss drug developer ...